Several biotech stocks made sharp moves in after-hours trading on Thursday, September 11, 2025, driven by clinical updates, strategic pivots, and rebranding efforts. Here's a quick look at what sparked the action.Modular Medical Inc. (MODD) saw a dramatic upswing in its stock price today, climbing 30.68% overnight to $0.9150, following a modest 1.27% gain at market close to $0.7002The rally was sparked by the company's announcement that it had completed a clinical study for its MODD1 insulin pump, a device ...

- Use of MODD1 on clinicians with Type 1 diabetes SAN DIEGO, CA / ACCESS Newswire / September 11, 2025 / Modular Medical, Inc. (Nasdaq:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to target the estimated $3 billion dollar adult "almost-pumpers" market with its user-friendly and affordable design, today announced the successful completion of a clinical study with the MODD1 pump. The MODD1 was worn by nine clinic ...